: iStockAnalyst.com Symbols Feed

Insider Buys And Sells: Weekly Wrap-up

Mon, 21 Sep 2009 13:38:00 GMT

For all the analysts and pundits in the financial media, there is still no better judge of a company's health and future prospects than the owners and executives of those companies themselves, along with major institutional shareholders.[More...]

The Panic Trade: A 20-Stock Defensive Growth Portfolio

Mon, 13 Oct 2008 00:37:00 GMT

[More...]

Periodicals Wrap-Up for Wednesday, August 13th

Wed, 13 Aug 2008 14:01:00 GMT

Posted By Optiondragon for myhappytrading.com[More...]

Mixed Earnings Signals

Wed, 23 Apr 2008 13:41:01 GMT

Good morning. Much like we saw both on Monday and Tuesday this week, premarket futures are mixed prior to the opening bell as investors sort through hundreds of earnings reports.[More...]

Yield to the Calamos Convertible Opportunities and Income Fund - Apr 22 2008 12:26AM

Tue, 22 Apr 2008 04:21:10 GMT

Yield to the Calamos Convertible Opportunities and Income Fund - Apr 18 2008 2:33AM

Fri, 18 Apr 2008 06:27:58 GMT

The Calamos Convertible Opportunities and Income Fund (CHI) is a CEF that attempts, through a combination of capital appreciation and current income, to provide optimum results investing in a diversified portfolio of convertible securities and below investment grade fixed income securities. According to the Calamos Fund managers (John Calamos and son Jack),"the Fund's enhanced fixed income strategy uses all ranges of credit quality and a variety of debt instruments to achieve its objective. The strategy provides an alternative to investment-grade fixed income instruments. Offering potential capital appreciation while delivering an attractive, stable monthly distribution, the Fund may be suitable for investors who are focused...[More...]

Herbalife (HLF) Added to Portfolio

Mon, 10 Mar 2008 15:41:09 GMT

One fascinating aspect of a mechanical portfolio is that it will get you long companies that you often not even consider dabbling in. Such is the case right now, as Portfolio A1 has seen fit to drop Invitrogen (IVGN) and replace it with Herbalife (HLF), a company whose core business is in nutritional supplements and weight management products.A year ago, the portfolio briefly held Herbalife competitor NBTY...[More...]

StemCells Inc.: Time to Play the Election

Thu, 07 Feb 2008 05:45:14 GMT

StemCells Inc. (NASDAQ:STEM) shares over the last 5 days have charged up 20%, fell 14%, and now are up 8% after hours. The only reason? The 2008 Presidential Election.[More...]

Looking For The Retest

Wed, 06 Feb 2008 16:27:24 GMT

Good morning. Traders are hoping for a Wednesday bounce following yesterday's meltdown.[More...]

100 Stocks That Made Money This Year

Mon, 21 Jan 2008 11:42:13 GMT

This has been the worst stock market start for US equities in... history. So instead of doing the weekly look at what is winning let's see what has been able to eek out a gain this year. Amazingly out of the entire universe of stocks with market cap of $2 billion or more, only 100 have a return >1%. 100 lonely souls. (and a couple at the top of the list seem like old acquisitions so they could be errors) About 10% of the list is the same theme.... you can see what I've highlighted....Market cap >$2 BillionAverage trading volume >100KStock Price >$10 [More...]

Life Technologies Gets Grant, Plans to Hire 50 Workers

Fri, 03 Apr 2009 21:03:00 GMT

Apr. 3--With the help of a state grant, a bio-tech company will hire 50 employees in Frederick and retain 250 workers.
Life Technologies Corp., at 7305 Executive Way, received a $250,000 investment from the state on Thursday.
He and Life Technologies Corp. CEO Greg Lucier then toured the $900,000, 6,600-square-foot space housing the firm's local operations.

[More...]

The Baltimore Sun On the Job Column: Starting Again

Fri, 06 Feb 2009 10:18:00 GMT

Feb. 6--There was a molecular biologist.
And three days this week, they packed a Columbia classroom to learn job-seeking strategies, interviewing skills, resume-writing techniques and how to network.
"You're in the sales and marketing business right now," career counselor Stephen Gallison told the nearly 50 professionals participating in the Maryland Professional Outplacement Assistance Center's JumpStart program.

[More...]

Invitrogen and Applied Biosystems Complete Merger

Fri, 21 Nov 2008 19:26:00 GMT

Invitrogen Corporation (NASDAQ:IVGN) and Applied Biosystems Inc. (NYSE:ABI) today announced the successful completion of their merger transaction. The new company will be named Life Technologies Corporation and will be traded on the NASDAQ Global Select Market under the ticker symbol "LIFE" beginning November 24, 2008.[More...]

Invitrogen and Applied Biosystems Announce Preliminary Results of Election Regarding Merger Consideration

Thu, 20 Nov 2008 12:26:00 GMT

Invitrogen Corporation (NASDAQ:IVGN) and Applied Biosystems Inc. (NYSE:ABI) today announced the preliminary results of elections made by Applied Biosystems stockholders regarding their preferences as to the form of merger consideration they will receive in the pending acquisition of Applied Biosystems by Invitrogen. The election deadline for Applied Biosystems stockholders to have made merger consideration elections in connection with the proposed merger was 5:00 p.m., EST, on November 19, 2008.[More...]

Invitrogen Launches In Vivo RNAi Delivery Reagent

Wed, 19 Nov 2008 20:00:00 GMT

Invitrogen Corporation (NASDAQ:IVGN), a provider of essential life science technologies for research, production and diagnostics, today announced the introduction of its Invivofectamine™ delivery reagent which enables short interference ribonucleic acid (siRNA) experiments in vivo.[More...]

Standard & Poor's Announces Changes to U.S. Indices - 17-11-08

Mon, 17 Nov 2008 22:40:00 GMT

Standard & Poor's will make the following changes to the S&P 100, S&P 500, S&P MidCap 400 and S&P SmallCap 600 indices:[More...]

Invitrogen and Applied Biosystems Announce European Commission Merger Clearance

Tue, 11 Nov 2008 16:32:00 GMT

Invitrogen Corporation (NASDAQ:IVGN) and Applied Biosystems Inc. (NYSE:ABI) today announced that they have received clearance from the European Commission for their proposed merger. This represents the last regulatory approval needed for the completion of the merger. The companies are now actively engaged in preparation for the closing of the merger, which is scheduled to occur on November 21, 2008. The closing remains subject to other customary closing conditions, which are expected to be satisfied on the scheduled closing date.[More...]

Invitrogen Launches Microarray to Study Non-Coding RNA

Thu, 06 Nov 2008 12:25:00 GMT

Invitrogen Corporation (NASDAQ:IVGN), a provider of essential life science technologies for research, production and diagnostics, today announced the launch of the first high-density microarray for the profiling of non-coding RNAs. The NCode™ Human and Mouse non-coding RNA microarrays consist of both non-coding RNA and messenger RNA (mRNA) content on the same array. The arrays are designed by Invitrogen and then manufactured by Agilent Technologies Inc. (NYSE:A), a technology leader in communications, electronics, life sciences and chemical analysis, using the company’s proprietary SurePrint technology.[More...]

Invitrogen Provides Update on Merger with Applied Biosystems

Tue, 04 Nov 2008 20:27:00 GMT

Invitrogen Corporation (NASDAQ:IVGN) today announced progress against its integration plans regarding its pending merger with Applied Biosystems.[More...]

Invitrogen Announces Third Quarter 2008 Financial Results

Tue, 21 Oct 2008 20:05:00 GMT

Invitrogen Corporation (Nasdaq:IVGN) today announced results for its third quarter ended September 30, 2008. Revenues for the third quarter were $362 million, an increase of 15 percent over the $315 million reported for the third quarter of 2007.[More...]

Invitrogen and Applied Biosystems Amend Merger Agreement to Eliminate Tax Opinion Condition; Stockholder Meetings to Be Moved to October 28, 2008

Wed, 15 Oct 2008 12:34:00 GMT

Invitrogen Corporation (NASDAQ:IVGN) and Applied Biosystems Inc. (NYSE:ABI) today announced that they have amended their pending merger agreement to eliminate a condition to closing requiring that the parties receive certain opinions of their respective counsel as to the tax treatment of the transaction.[More...]

Invitrogen Launches Countess(TM)

Fri, 10 Oct 2008 12:02:00 GMT

Invitrogen Corporation (NASDAQ:IVGN), a provider of essential life science technologies for research, production and diagnostics, today announced the introduction of a new benchtop instrument, Countess™ automated cell counter, which offers a new method of automated cell counting to replace manual cell counting using a glass hemocytometer.[More...]